Literature DB >> 16242329

N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.

Cristina Campestre1, Mariangela Agamennone, Paolo Tortorella, Serena Preziuso, Alessandro Biasone, Enrico Gavuzzo, Giorgio Pochetti, Fernando Mazza, Oliver Hiller, Harald Tschesche, Valerio Consalvi, Carlo Gallina.   

Abstract

The first crystallographic structure of an N-hydroxyurea inhibitor bound into the active site of a matrix metalloproteinase is reported. The ligand and three other analogues were prepared and studied as inhibitors of MMP-2, MMP-3, and MMP-8. The crystal structure of the complex with MMP-8 shows that the N-hydroxyurea, contrary to the analogous hydroxamate, binds the catalytic zinc ion in a monodentate rather than bidentate mode and with high out-of-plane distortion of the amide bonds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242329     DOI: 10.1016/j.bmcl.2005.09.057

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.

Authors:  Giulia Palermo; Davide Branduardi; Matteo Masetti; Alessio Lodola; Marco Mor; Daniele Piomelli; Andrea Cavalli; Marco De Vivo
Journal:  J Med Chem       Date:  2011-09-08       Impact factor: 7.446

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

3.  Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster.

Authors:  Luigi Di Costanzo; Michael E Pique; David W Christianson
Journal:  J Am Chem Soc       Date:  2007-05-01       Impact factor: 15.419

Review 4.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

5.  Ultratight crystal packing of a 10 kDa protein.

Authors:  Sergio Trillo-Muyo; Andrius Jasilionis; Marcin J Domagalski; Maksymilian Chruszcz; Wladek Minor; Nomeda Kuisiene; Joan L Arolas; Maria Solà; F Xavier Gomis-Rüth
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-02-16

6.  Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.

Authors:  Jacob D Durrant; César A F de Oliveira; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2011-06-20       Impact factor: 2.817

7.  Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.

Authors:  Caiguo Zhang; Guoqi Liu; Mingxia Huang
Journal:  Front Biol (Beijing)       Date:  2014-01-02

8.  Zinc-binding groups modulate selective inhibition of MMPs.

Authors:  Arpita Agrawal; Diego Romero-Perez; Jennifer A Jacobsen; Francisco J Villarreal; Seth M Cohen
Journal:  ChemMedChem       Date:  2008-05       Impact factor: 3.466

9.  Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.

Authors:  Jacob D Durrant; César Augusto F de Oliveira; J Andrew McCammon
Journal:  J Mol Recognit       Date:  2010 Mar-Apr       Impact factor: 2.137

10.  Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.

Authors:  Bornali Chakrabarti; Hridoy R Bairagya; Deepak Kr Mishra; Pradip Kumar Chatterjee; Bishnu P Mukhopadhyay
Journal:  Bioinformation       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.